首页> 外文OA文献 >Clinical Staging of Stage I Non-Small Cell Lung Cancer in the Netherlands—Need for Improvement in an Era With Expanding Nonsurgical Treatment Options: Data From the Dutch Lung Surgery Audit

【2h】

Clinical Staging of Stage I Non-Small Cell Lung Cancer in the Netherlands—Need for Improvement in an Era With Expanding Nonsurgical Treatment Options: Data From the Dutch Lung Surgery Audit

机译：荷兰I阶段I阶段的临床分期 - 需要改进时代，以扩大非诊断治疗方案：来自荷兰肺手术审计的数据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
David Jonathan Heineman; Martijn Geert ten Berge; Johannes Marlene Daniels; Michaël Ignatius Versteegh; Perla Jacqueline Marang-van de Mheen; Michael Wilhelmus Wouters; Wilhelmina Hendrika Schreurs;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Clinical Staging of Stage I Non-Small Cell Lung Cancer in the Netherlands—Need for Improvement in an Era With Expanding Nonsurgical Treatment Options: Data From the Dutch Lung Surgery Audit [J] . David Jonathan Heineman, Martijn Geert ten Berge, Johannes Marlene Daniels, The Annals of Thoracic Surgery: Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association . 2016,第5期

机译：荷兰I阶段I阶段的临床分期 - 需要改进时代，以扩大非诊断治疗方案：来自荷兰肺手术审计的数据
2. Adherence to the mediastinal staging guideline and unforeseen N2 disease in patients with resectable non-small cell lung cancer: Nationwide results from the Dutch Lung Cancer Audit - Surgery [J] . Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2020,第期

机译：可重复的非小细胞肺癌患者遵守纵隔分期指南和未预见的N2病：全国荷兰肺癌审计 - 手术的结果
3. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Elderly Stage III Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation [J] . Belderbos J., van der Woude L., van Bockel L. W., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：荷兰肺癌审计 - 放射治疗（DLCA-R）：患有明确校长治疗的老年人阶段非小细胞肺癌的现实世界数据
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Nivolumab in pre-treated advanced non-small cell lung cancer: long term follow up data from the Dutch expanded access program and routine clinical care [O] . Robert D. Schouten, Lucie Egberink, Mirte Muller, 2020

机译：Nivolumab在预处理的晚期非小细胞肺癌中：长期跟进来自荷兰的访问程序和常规临床护理
7. The Quality of Staging Non-Small Cell Lung Cancer in the Netherlands: Data From the Dutch Lung Surgery Audit [O] . David Jonathan Heineman, Martijn Geert ten Berge, Johannes Marlene Daniels, 2016

机译：荷兰中期非小细胞肺癌的质量：来自荷兰肺手术审计的数据

Clinical Staging of Stage I Non-Small Cell Lung Cancer in the Netherlands—Need for Improvement in an Era With Expanding Nonsurgical Treatment Options: Data From the Dutch Lung Surgery Audit

著录项

相似文献

相关主题

期刊订阅